The National Plan to address Alzheimer’s, set forth by the President of the United States, has set a goal to provide accurate diagnostic testing and effective treatments for individuals with symptoms of Alzheimer’s Dementia by 2025. The 2015 Alzheimer’s Association International Conference reported very promising data from the ongoing Alzheimer’s research trials. Many of these new investigational agents may provide cognitive stability.
The Compass Clinic is a partner of the Bioclinica Research Site Network. With this partnership, The Compass Clinic offers the opportunity to its patients to be a part of groundbreaking research in the following conditions:
NY Times Interview with Dr. Goodman
By: Gina Kolata
Evaluating Patients with Cognitive Changes: A New Imaging Option
By: Anamaria Shanley, MSN, ARNP-BC; Ira J. Goodman, MD; Nima Khosravani, MS; Kurt Cicilioni, BS
Case Report: Meningeal Enhancement Seen on Workup for Memory Loss
By: Nima Khosravani, MS; Anamaria Shanley, MSN, ARNP-BC; and Ira J. Goodman, MD
Is It Alzheimer Disease Guidelines for Evaluating Patients With Mild Memory Loss.pdf
By: Anamaria Shanley, MSN, ARNP-BC
In order to better assist our patients, Neha Majid is conveniently available in our office to discuss current research studies. You can reach her by calling 407-210-1157.
Copyright © Compass Clinic. All rights reserved.
100 W. Gore Street, Suite 406, Orlando, FL 32806 | T: (407) 210-1320 | F: (321) 202-2582 | www.Compass-Clinic.com